The commercial success of GLP-1 receptor agonists has done something unusual for a pharmaceutical category: it has generated an entirely new HealthTech sector almost overnight. …
The commercial success of GLP-1 receptor agonists has done something unusual for a pharmaceutical category: it has generated an entirely new HealthTech sector almost overnight. …
With gyms closed and fitness classes curtailed, the past year has seen a surge in the use of digital fitness technology to help bridge the…